• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临时和永久起搏器植入延迟:原因及院内结局

Delays in Temporary and Permanent Pacemakers: Causes and In-Hospital Outcomes.

作者信息

Irfan Muhammad, Khan Imran, Ullah Bacha Kaleem

机构信息

Cardiology, Lady Reading Hospital, Peshawar, PAK.

Cardiology/Clinical Cardiac Electrophysiology, Lady Reading Hospital, Peshawar, PAK.

出版信息

Cureus. 2020 Feb 11;12(2):e6953. doi: 10.7759/cureus.6953.

DOI:10.7759/cureus.6953
PMID:32190503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7067517/
Abstract

Background Temporary pacemakers frequently serve as a bridge to permanent pacemakers, but placement of the latter may be delayed. This study assessed the causes and in-hospital outcomes of patients with delayed placement of permanent pacemakers. Methods This retrospective study included all patients admitted to the Emergency Department who underwent temporary transvenous pacing in the Department of Cardiology, Lady Reading Hospital, Peshawar, Pakistan. The duration of hospitalization and the time from temporary to permanent placement were calculated in days. Asystole, infections, cardiac arrest, and death were recorded during the waiting period. Results Of the 260 patients who underwent temporary transvenous pacing, 136 (52.3%) were males and 124 (47.7%) were females, with an age range of 46-78 years. Coronary artery disease was prevalent in 34% of the patients. Only 5% of the patients were on arteriovenous (AV) nodal blocking agents, 44% had complete AV block, 22% had sinus node disease, and 14% had slow atrial fibrillation. The cause of high-degree AV block could not be determined in most patients. Most patients with ischemia- and hyperkalemia-induced AV block recovered. AV blocks induced by ischemia and with no known cause were not reversible, with most of these patients receiving permanent pacemakers. Of the 260 patients with high-degree AV block, 165 (63.5%) recovered. The mean waiting time for permanent pacemaker implantation was 8.7 ± 5.4 days. The waiting time was associated with increased infections and adverse hospital course. Conclusion A longer waiting period between permanent pacemaker indication and implantation is dangerous, as it is associated with an increased risk of adverse events such as infections, syncope, asystole, malignant arrhythmias, cardiac arrest, and death.

摘要

背景

临时起搏器常作为过渡到永久起搏器的桥梁,但永久起搏器的植入可能会延迟。本研究评估了永久起搏器植入延迟患者的原因及住院期间的结局。

方法

这项回顾性研究纳入了所有在巴基斯坦白沙瓦莱迪夫人医院心脏病科接受临时经静脉起搏的急诊科住院患者。住院时间和从临时起搏到永久植入的时间以天计算。记录等待期间的心脏停搏、感染、心脏骤停和死亡情况。

结果

在260例接受临时经静脉起搏的患者中,男性136例(52.3%),女性124例(47.7%),年龄范围为46 - 78岁。34%的患者患有冠状动脉疾病。仅5%的患者使用房室结阻滞剂,44%有完全性房室传导阻滞,22%有窦房结疾病,14%有缓慢型心房颤动。大多数患者无法确定高度房室传导阻滞的原因。大多数因缺血和高钾血症诱发的房室传导阻滞患者恢复。由缺血诱发且原因不明的房室传导阻滞不可逆性,这些患者大多接受了永久起搏器植入。在260例高度房室传导阻滞患者中,165例(63.5%)恢复。永久起搏器植入的平均等待时间为8.7±5.4天。等待时间与感染增加及不良住院病程相关。

结论

永久起搏器适应证与植入之间的等待时间延长是危险的,因为它与感染、晕厥、心脏停搏、恶性心律失常、心脏骤停和死亡等不良事件的风险增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7388/7067517/baf552b23561/cureus-0012-00000006953-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7388/7067517/47e653ee8137/cureus-0012-00000006953-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7388/7067517/baf552b23561/cureus-0012-00000006953-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7388/7067517/47e653ee8137/cureus-0012-00000006953-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7388/7067517/baf552b23561/cureus-0012-00000006953-i02.jpg

相似文献

1
Delays in Temporary and Permanent Pacemakers: Causes and In-Hospital Outcomes.临时和永久起搏器植入延迟:原因及院内结局
Cureus. 2020 Feb 11;12(2):e6953. doi: 10.7759/cureus.6953.
2
Rate of various access sites for temporary transvenous pacing and different outcomes at Lady Reading Hospital, Peshawar Pakistan.巴基斯坦白沙瓦莱迪德医院临时经静脉起搏不同穿刺部位的发生率及不同结局
Pak J Med Sci. 2023 Jul-Aug;39(4):1101-1107. doi: 10.12669/pjms.39.4.7467.
3
A Review of Temporary Permanent Pacemakers and a Comparison with Conventional Temporary Pacemakers.临时永久性起搏器综述及其与传统临时起搏器的比较。
J Innov Card Rhythm Manag. 2019 May 15;10(5):3652-3661. doi: 10.19102/icrm.2019.100506. eCollection 2019 May.
4
The impact of drug discontinuation in patients treated with temporary pacemaker due to atrioventricular block.因房室传导阻滞接受临时起搏器治疗的患者停用药物的影响。
J Cardiovasc Electrophysiol. 2013 Nov;24(11):1255-8. doi: 10.1111/jce.12211. Epub 2013 Jul 19.
5
Atrioventricular Synchrony Restoration Aided by a Temporary Permanent Pacemaker in Right Ventricular Infarction and Complete Heart Block.临时永久性起搏器辅助恢复右心室梗死并完全性心脏传导阻滞患者的房室同步性
Cureus. 2024 Feb 21;16(2):e54631. doi: 10.7759/cureus.54631. eCollection 2024 Feb.
6
Clinical Outcomes of Various Management Strategies for Symptomatic Bradycardia.各种有症状心动过缓处理策略的临床结局。
Clin Med Res. 2020 Aug;18(2-3):75-81. doi: 10.3121/cmr.2019.1507. Epub 2020 Feb 14.
7
Permanent and temporary pacemaker implantation after orthotopic heart transplantation.原位心脏移植后永久性和临时性起搏器植入
Arq Bras Cardiol. 2000 Jan;74(1):5-12.
8
Permanent and temporary pacemaker implantation after orthotopic heart transplantation.原位心脏移植后永久性和临时性起搏器植入
Arq Bras Cardiol. 2000 Jan;74(1):9-12.
9
Temporary transvenous VDD pacing as a bridge to permanent pacemaker implantation in patients with sepsis and haemodynamically significant atrioventricular block.在患有败血症和具有临床意义的房室传导阻滞的患者中,临时经静脉 VDD 起搏作为永久性起搏器植入的桥接。
Europace. 2012 Jul;14(7):981-5. doi: 10.1093/europace/eur403. Epub 2012 Jan 2.
10
Emergency medicine-trained physicians are proficient in the insertion of transvenous pacemakers.接受过急诊医学培训的医生精通经静脉起搏器的植入。
Ann Emerg Med. 2004 Apr;43(4):469-74. doi: 10.1016/j.annemergmed.2003.09.019.

引用本文的文献

1
Rate of various access sites for temporary transvenous pacing and different outcomes at Lady Reading Hospital, Peshawar Pakistan.巴基斯坦白沙瓦莱迪德医院临时经静脉起搏不同穿刺部位的发生率及不同结局
Pak J Med Sci. 2023 Jul-Aug;39(4):1101-1107. doi: 10.12669/pjms.39.4.7467.
2
Myringosclerosis as a predictor of the requirement for a permanent pacemaker in patients with drug-related atrioventricular block.鼓膜硬化作为药物相关性房室传导阻滞患者永久起搏器植入需求的预测指标。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Dec;166(4):412-417. doi: 10.5507/bp.2022.030. Epub 2022 Jun 21.
3
Clinical analysis of temporary pacemaker implantation in 13 children.

本文引用的文献

1
Waiting for a pacemaker: is it dangerous?等待心脏起搏器:是否有危险?
Europace. 2012 Jul;14(7):975-80. doi: 10.1093/europace/eus016. Epub 2012 Feb 14.
2
Pacing technology: advances in pacing threshold management.起搏技术:起搏阈值管理的进展。
J Zhejiang Univ Sci B. 2010 Aug;11(8):634-8. doi: 10.1631/jzus.B1001016.
3
Delays and adverse clinical outcomes associated with unrecognized pacing indications.与未识别的起搏适应证相关的延误和不良临床结局。
13例儿童临时起搏器植入的临床分析
Transl Pediatr. 2022 Feb;11(2):174-182. doi: 10.21037/tp-21-586.
4
Strategies to Promote Long-Term Cardiac Implant Site Health.促进心脏植入部位长期健康的策略。
Cureus. 2021 Jan 3;13(1):e12457. doi: 10.7759/cureus.12457.
QJM. 2009 Jul;102(7):485-90. doi: 10.1093/qjmed/hcp066. Epub 2009 May 27.
4
The patient journey from symptom onset to pacemaker implantation.从症状出现到起搏器植入的患者就医过程。
QJM. 2008 Dec;101(12):955-60. doi: 10.1093/qjmed/hcn122. Epub 2008 Sep 27.
5
Poor health-related quality of life of patients with indication for chronic cardiac pacemaker therapy.
Pacing Clin Electrophysiol. 2008 Apr;31(4):480-6. doi: 10.1111/j.1540-8159.2008.01018.x.
6
Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.心脏起搏与心脏再同步治疗指南。欧洲心脏病学会心脏起搏与心脏再同步治疗工作组。与欧洲心律协会合作制定。
Europace. 2007 Oct;9(10):959-98. doi: 10.1093/europace/eum189. Epub 2007 Aug 28.
7
Compromising bradycardia: management in the emergency department.危及生命的心动过缓:急诊科的处理
Resuscitation. 2007 Apr;73(1):96-102. doi: 10.1016/j.resuscitation.2006.08.006. Epub 2007 Jan 8.
8
Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery.肾功能不全与起搏器或除颤器手术的感染风险。
Pacing Clin Electrophysiol. 2006 Feb;29(2):142-5. doi: 10.1111/j.1540-8159.2006.00307.x.
9
Regional survey of temporary transvenous pacing procedures and complications.临时经静脉起搏操作及并发症的区域调查。
Postgrad Med J. 2003 Aug;79(934):463-5. doi: 10.1136/pmj.79.934.463.
10
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).美国心脏病学会/美国心脏协会/北美心脏起搏与电生理学会2002年心脏起搏器与抗心律失常器械植入指南更新:总结篇:美国心脏病学会/美国心脏协会实践指南工作组(美国心脏病学会/美国心脏协会/北美心脏起搏与电生理学会1998年起搏器指南更新委员会)报告
Circulation. 2002 Oct 15;106(16):2145-61. doi: 10.1161/01.cir.0000035996.46455.09.